[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647
Sort by:

Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Central Nerv...

April 2021 35 pages

Central Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Central Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021 SUMMARY Central Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Central Reti...

April 2021 30 pages

Cerebral Edema (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Cerebral Edema (Central Nervous System) - Drugs in Development, 2021 SUMMARY Cerebral Edema (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Cerebral Edema pipeline la...

April 2021 30 pages

Cerebral (Fatal) Malaria (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Cerebral (Fatal) Malaria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Cerebral (Fatal) Malaria (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Cerebral (Fata...

April 2021 30 pages

Cerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Cerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Cerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021 provid...

April 2021 45 pages

Cerebrovascular Disease (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Cerebrovascular Disease (Cardiovascular) - Drugs in Development, 2021 SUMMARY Cerebrovascular Disease (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Cerebrovascular Disease...

April 2021 35 pages

Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Charcot-Ma...

April 2021 40 pages

Charcot-Marie-Tooth Disease Type I A (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Charcot-Marie-Tooth Disease Type I A (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Charcot-Marie-Tooth Disease Type I A (Genetic Disorders) - Drugs in Development, 2021 provides an overview...

April 2021 45 pages

Charcot-Marie-Tooth Disease Type II (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Charcot-Marie-Tooth Disease Type II (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Charcot-Marie-Tooth Disease Type II (Genetic Disorders) - Drugs in Development, 2021 provides an overview o...

April 2021 35 pages

Chemotherapy Effects (Toxicology) - Drugs in Development, 2021

 US$ 2,000.00

Chemotherapy Effects (Toxicology) - Drugs in Development, 2021 SUMMARY Chemotherapy Effects (Toxicology) - Drugs in Development, 2021 provides an overview of the Chemotherapy Effects pipeline landscap...

April 2021 90 pages

Chemotherapy-Induced Diarrhea (CID) (Toxicology) - Drugs in Development, 2021

 US$ 2,000.00

Chemotherapy-Induced Diarrhea (CID) (Toxicology) - Drugs in Development, 2021 SUMMARY Chemotherapy-Induced Diarrhea (CID) (Toxicology) - Drugs in Development, 2021 provides an overview of the Chemothe...

April 2021 30 pages

Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021 SUMMARY Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021 provides an overview of the Chemothe...

April 2021 35 pages

Chemotherapy Induced Oral Mucositis (Toxicology) - Drugs in Development, 2021

 US$ 2,000.00

Chemotherapy Induced Oral Mucositis (Toxicology) - Drugs in Development, 2021 SUMMARY Chemotherapy Induced Oral Mucositis (Toxicology) - Drugs in Development, 2021 provides an overview of the Chemothe...

April 2021 40 pages

Chemotherapy Induced Pain (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Chemotherapy Induced Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Chemotherapy Induced Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Chem...

April 2021 35 pages

Childhood Epilepsy (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Childhood Epilepsy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Childhood Epilepsy (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Childhood Epilepsy...

April 2021 30 pages

Chlamydia Trachomatis Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Chlamydia Trachomatis Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Chlamydia Trachomatis Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of th...

April 2021 30 pages

Cholestasis (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Cholestasis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Cholestasis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Cholestasis pipeline landscape. The report p...

April 2021 30 pages

Cholinergic Receptor Muscarinic (Muscarinic Acetylcholine Receptor or CHRM) - Drugs in Development, 2021

 US$ 3,000.00

Cholinergic Receptor Muscarinic (Muscarinic Acetylcholine Receptor or CHRM) - Drugs in Development, 2021 SUMMARY Cholinergic Receptor Muscarinic (Muscarinic Acetylcholine Receptor or CHRM) - Drugs in...

April 2021 85 pages

Cholinergic Receptor Nicotinic Subunit (Nicotinic Acetylcholine Receptor or CHRN) - Drugs in Development, 2021

 US$ 3,000.00

Cholinergic Receptor Nicotinic Subunit (Nicotinic Acetylcholine Receptor or CHRN) - Drugs in Development, 2021 SUMMARY Cholinergic Receptor Nicotinic Subunit (Nicotinic Acetylcholine Receptor or CHRN)...

April 2021 35 pages

Chordoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Chordoma (Oncology) - Drugs in Development, 2021 SUMMARY Chordoma (Oncology) - Drugs in Development, 2021 provides an overview of the Chordoma pipeline landscape. The report provides comprehensive inf...

April 2021 55 pages

Choroidal Neovascularization (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Choroidal Neovascularization (Ophthalmology) - Drugs in Development, 2021 SUMMARY Choroidal Neovascularization (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Choroidal Neovas...

April 2021 65 pages

Choroideremia (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Choroideremia (Ophthalmology) - Drugs in Development, 2021 SUMMARY Choroideremia (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Choroideremia pipeline landscape. The report p...

April 2021 30 pages

Chronic Bronchitis (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Bronchitis (Respiratory) - Drugs in Development, 2021 SUMMARY Chronic Bronchitis (Respiratory) - Drugs in Development, 2021 provides an overview of the Chronic Bronchitis pipeline landscape. T...

April 2021 30 pages

Chronic Cough (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Cough (Respiratory) - Drugs in Development, 2021 SUMMARY Chronic Cough (Respiratory) - Drugs in Development, 2021 provides an overview of the Chronic Cough pipeline landscape. The report provi...

April 2021 40 pages

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) (Immunology) - Drugs in Development, 2021 SUMMARY Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythema...

April 2021 30 pages

Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) (Central Nervous System) - Drugs...

April 2021 30 pages

Chronic Granulomatous Disease (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Granulomatous Disease (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Chronic Granulomatous Disease (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Chroni...

April 2021 30 pages

Chronic Heart Failure (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Heart Failure (Cardiovascular) - Drugs in Development, 2021 SUMMARY Chronic Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Chronic Heart Failure pipeli...

April 2021 70 pages

Chronic Inflammation (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Inflammation (Immunology) - Drugs in Development, 2021 SUMMARY Chronic Inflammation (Immunology) - Drugs in Development, 2021 provides an overview of the Chronic Inflammation pipeline landscap...

April 2021 115 pages

Chronic Liver Disease (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Liver Disease (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Chronic Liver Disease (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Chronic Liver Disease pi...

April 2021 40 pages

Chronic Myelomonocytic Leukemia (CMML) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Myelomonocytic Leukemia (CMML) (Oncology) - Drugs in Development, 2021 SUMMARY Chronic Myelomonocytic Leukemia (CMML) (Oncology) - Drugs in Development, 2021 provides an overview of the Chroni...

April 2021 95 pages

Chronic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Chronic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Ch...

April 2021 30 pages

Chronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 SUMMARY Chronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 provides...

April 2021 30 pages

Chronic Traumatic Encephalopathy (CTE) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Chronic Traumatic Encephalopathy (CTE) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Chronic Traumatic Encephalopathy (CTE) (Central Nervous System) - Drugs in Development, 2021 provid...

April 2021 40 pages

Churg-Strauss Syndrome (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Churg-Strauss Syndrome (Immunology) - Drugs in Development, 2021 SUMMARY Churg-Strauss Syndrome (Immunology) - Drugs in Development, 2021 provides an overview of the Churg-Strauss Syndrome pipeline la...

April 2021 30 pages

Circadian Rhythm Sleep Disorders (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Circadian Rhythm Sleep Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Circadian Rhythm Sleep Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overvi...

April 2021 35 pages

Cirrhosis (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Cirrhosis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Cirrhosis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Cirrhosis pipeline landscape. The report provide...

April 2021 35 pages

Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) (Genetic Disorders) -...

April 2021 30 pages

Claudin 18 (CLDN18) - Drugs in Development, 2021

 US$ 3,000.00

Claudin 18 (CLDN18) - Drugs in Development, 2021 SUMMARY Claudin 18 (CLDN18) - Drugs in Development, 2021 provides in depth analysis on Claudin 18 (CLDN18) targeted pipeline therapeutics. The report p...

April 2021 35 pages

Clostridium difficile Toxin A (toxA or EC 3.4.22.) - Drugs in Development, 2021

 US$ 3,000.00

Clostridium difficile Toxin A (toxA or EC 3.4.22.) - Drugs in Development, 2021 SUMMARY Clostridium difficile Toxin A (toxA or EC 3.4.22.) - Drugs in Development, 2021 provides in depth analysis on Cl...

April 2021 45 pages

Clostridium difficile Toxin B (toxB or EC 3.4.22.) - Drugs in Development, 2021

 US$ 3,000.00

Clostridium difficile Toxin B (toxB or EC 3.4.22.) - Drugs in Development, 2021 SUMMARY Clostridium difficile Toxin B (toxB or EC 3.4.22.) - Drugs in Development, 2021 provides in depth analysis on Cl...

April 2021 45 pages

CNS Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

CNS Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY CNS Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the CNS Lymphoma pipeline landscape. The report provides compr...

April 2021 30 pages

Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin Component or F9 or EC 3.4.21.22) - Drugs in Development, 2021

 US$ 3,000.00

Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin Component or F9 or EC 3.4.21.22) - Drugs in Development, 2021 SUMMARY Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin...

April 2021 60 pages

Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Component or F8) - Drugs in Development, 2021

 US$ 3,000.00

Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Component or F8) - Drugs in Development, 2021 SUMMARY Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Compon...

April 2021 95 pages

Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21.6) - Drugs in Development, 2021

 US$ 3,000.00

Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21.6) - Drugs in Development, 2021 SUMMARY Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21....

April 2021 60 pages

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021

 US$ 3,000.00

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021 SUMMARY Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development,...

April 2021 35 pages

Cognitive Impairment (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Cognitive Impairment (Central Nervous System) - Drugs in Development, 2021 SUMMARY Cognitive Impairment (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Cognitive Impa...

April 2021 75 pages

Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) - Drugs in Development, 2021

 US$ 3,000.00

Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) - Drugs in Development, 2021 SUMMARY Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) - Drugs in Development, 2021 provides in de...

April 2021 35 pages

Colon Carcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Colon Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Colon Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Colon Carcinoma pipeline landscape. The report provi...

April 2021 75 pages

Community-Acquired Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Community-Acquired Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Community-Acquired Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021 provides an ov...

April 2021 35 pages

Filters

Clear all

Search

Categories

154
14,886
12,075
344
72
1,116

Publishers

72
1
3,298
1,760
342
155
531
292
33
4
2,060
635
92
8
109
111
554
55
5
5
6
23
18
27
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
84
4
26
50
1
141
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
81
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
247
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
184
13
12
8
431
236
126
56
49
33
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
26,041

Price

—

Date

—

Pages

—

Offers

44
5
1